Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Deferasirox
Drug ID BADD_D00594
Description Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.
Indications and Usage For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Marketing Status Prescription
ATC Code V03AC03
DrugBank ID DB01609
KEGG ID D03669
MeSH ID D000077588
PubChem ID 214348
TTD Drug ID D0Q5UQ
NDC Product Code 62332-412; 43598-856; 57664-769; 62332-411; 62756-569; 0078-0469; 70771-1411; 66039-871; 69097-550; 70771-1471; 72647-371; 62512-0078; 68462-494; 69539-021; 31722-012; 69097-391; 57664-770; 58032-2017; 69539-200; 63278-1070; 72647-372; 46708-324; 69452-159; 62332-410; 53104-7713; 72606-014; 11722-040; 69097-570; 43598-851; 62332-324; 67877-549; 69539-022; 66022-0301; 0591-3853; 45963-456; 14501-0049; 46708-410; 62332-325; 46708-879; 72606-013; 62756-570; 69238-1486; 43598-854; 65085-0063; 62332-326; 69238-1704; 70710-1011; 59285-010; 46708-326; 70710-1012; 59651-419; 16714-995; 69539-199; 72205-076; 65727-037; 74436-0323; 57664-768; 68462-495; 46708-325; 69452-160; 0078-0713; 65015-738; 16714-993; 69097-393; 69097-560; 0078-0470; 31722-013; 69539-074; 43598-853; 70700-269; 70771-1409; 49706-2103; 70710-1277; 43598-855; 0078-0468; 65372-1164; 16714-994; 43598-852; 45963-455; 46708-412; 0078-0727; 70771-1472; 72647-373; 68462-496; 67877-553; 69238-1703; 45963-454; 69452-161; 0078-0654; 62756-568; 70771-1473; 69539-023; 67877-550; 0078-0720; 70710-1275; 31722-011; 72606-015; 70771-1410; 69539-075; 67877-551; 70710-1013; 67877-554; 72205-075; 0078-0656; 70700-270; 69238-1702; 0078-0655; 46708-411; 69097-392; 69539-073; 69238-1487; 67877-552; 70700-271; 70710-1276; 69238-1488
Synonyms Deferasirox | 4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid | ICL 670A | ICL-670A | ICL670A | ICL-670 | ICL670 | ICL 670 | Exjade
Chemical Information
Molecular Formula C21H15N3O4
CAS Registry Number 201530-41-8
SMILES C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Myelodysplastic syndrome transformation01.10.04.005; 16.01.04.0050.012169%Not Available
Low birth weight baby18.04.02.003--Not Available
Gastrointestinal sounds abnormal07.01.01.0020.005831%Not Available
Anorectal discomfort07.03.03.0030.005831%Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
Acute kidney injury20.01.03.016--
Gastrointestinal tract irritation07.08.03.0080.017494%Not Available
Posterior reversible encephalopathy syndrome17.13.02.0070.008747%
Functional gastrointestinal disorder07.11.01.0160.005831%Not Available
Drug-induced liver injury12.03.01.044; 09.01.07.023--Not Available
Hepatic cancer16.07.02.004; 09.04.02.0080.005324%Not Available
Hepatocellular carcinoma16.07.02.005; 09.04.02.010--Not Available
Autoimmune haemolytic anaemia10.04.01.005; 01.06.01.0040.008747%Not Available
Aspergillus infection11.03.01.0040.002282%Not Available
Mouth swelling07.05.04.007; 23.04.01.020; 10.01.05.0200.005831%Not Available
Multiple organ dysfunction syndrome08.01.03.0570.011409%
Liver function test increased13.03.01.0440.043734%Not Available
Abnormal loss of weight14.03.02.0190.005831%Not Available
Brain neoplasm malignant17.20.04.002; 16.30.04.0020.001521%Not Available
Chronic gastritis11.07.01.016; 10.04.04.011; 07.08.02.0050.005831%Not Available
Concomitant disease aggravated08.01.03.0630.007606%Not Available
Dengue fever23.09.03.011; 11.05.23.0010.017494%Not Available
Full blood count decreased13.01.07.004--Not Available
Granulocyte count increased13.01.06.0530.005831%Not Available
Haemosiderosis14.13.03.004; 12.02.08.0070.005324%Not Available
Moyamoya disease24.01.04.016; 17.08.02.0230.002282%Not Available
Normal newborn18.08.06.0010.008747%Not Available
Nosocomial infection11.07.02.0060.005324%Not Available
PCO2 decreased13.02.01.0290.005831%Not Available
Renal atrophy20.01.06.0010.005831%Not Available
The 26th Page    First    Pre   26 27 28    Next   Last    Total 28 Pages